News - Pernix Therapeutics, Mergers & Acquisitions


Popular Filters

Pernix Thera rescues struggling Somaxon with stock deal worth $25 million


Troubled US drugmaker Somaxon Pharmaceuticals (Nasdaq: SOMX) saw its shares leap around 85% to $2.74…

Mergers & AcquisitionsPernix TherapeuticsPharmaceuticalSilenorSomaxon Pharmaceuticals

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma


US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

Back to top